INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 June 2014
Net Assets |
£193m |
Net Assets per share |
355p |
Share price |
299p |
Total value of unquoted investments |
£18m |
Total number of portfolio companies |
90 |
Top Ten Holdings
Company Name |
% NAV |
Gilead |
8.4 |
Celgene |
7.6 |
Alexion |
7.4 |
Biogen |
7.0 |
Amgen |
5.6 |
Vertex |
5.2 |
Illumina |
4.2 |
Biomarin |
3.6 |
Shire |
3.3 |
Mylan |
3.2 |
|
----------- |
Total |
55.5 |
Portfolio Profitability |
% NAV |
Profitable |
59 |
Turning Profitable 2015 |
11 |
Unprofitable |
30 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
United States & Canada |
88 |
Europe & UK |
12 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
92 |
Unquoted |
8 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
21 JULY 2014